Zoe D. Draelos, MD

Article Type

Article

Changed

Thu, 01/10/2019 - 12:23

Display Headline

The Appearance of Facial Foundation Cosmetics Applied After Metronidazole Gel 1%

Author(s)

Zoe D. Draelos, MD

Luz E. Colón, MS, CCRC, CCRA

Norman Preston, PhD

Lori A. Johnson, PhD

Ronald W. Gottschalk, MD, FRCPC

Article PDF

087050251.pdf

Author and Disclosure Information

Dr. Draelos is from Dermatology Consulting Services, High Point, North Carolina. Ms. Colón and Drs. Preston, Johnson, and Gottschalk are from Galderma Laboratories, LP, Fort Worth, Texas.

This study and the development of this article were funded by Galderma Laboratories, LP. Dr. Draelos is a researcher for Galderma Laboratories, LP. Ms. Colón and Drs. Preston, Johnson, and Gottschalk are employees of Galderma Laboratories, LP.

The study was registered on April 25, 2008 at www.clinicaltrials.gov with the identifier of NCT00668655.

Correspondence: Lori A. Johnson, PhD ([email protected]).

Issue

Cutis - 87(5)

Publications

Cutis

MDedge Dermatology

Topics

Rosacea

Page Number

251-259

Read more about The Appearance of Facial Foundation Cosmetics Applied After Metronidazole Gel 1%

Sections

Original Research

Author(s)

Zoe D. Draelos, MD

Luz E. Colón, MS, CCRC, CCRA

Norman Preston, PhD

Lori A. Johnson, PhD

Ronald W. Gottschalk, MD, FRCPC

Author(s)

Zoe D. Draelos, MD

Luz E. Colón, MS, CCRC, CCRA

Norman Preston, PhD

Lori A. Johnson, PhD

Ronald W. Gottschalk, MD, FRCPC

Author and Disclosure Information

Dr. Draelos is from Dermatology Consulting Services, High Point, North Carolina. Ms. Colón and Drs. Preston, Johnson, and Gottschalk are from Galderma Laboratories, LP, Fort Worth, Texas.

This study and the development of this article were funded by Galderma Laboratories, LP. Dr. Draelos is a researcher for Galderma Laboratories, LP. Ms. Colón and Drs. Preston, Johnson, and Gottschalk are employees of Galderma Laboratories, LP.

The study was registered on April 25, 2008 at www.clinicaltrials.gov with the identifier of NCT00668655.

Correspondence: Lori A. Johnson, PhD ([email protected]).

Author and Disclosure Information

Dr. Draelos is from Dermatology Consulting Services, High Point, North Carolina. Ms. Colón and Drs. Preston, Johnson, and Gottschalk are from Galderma Laboratories, LP, Fort Worth, Texas.

This study and the development of this article were funded by Galderma Laboratories, LP. Dr. Draelos is a researcher for Galderma Laboratories, LP. Ms. Colón and Drs. Preston, Johnson, and Gottschalk are employees of Galderma Laboratories, LP.

The study was registered on April 25, 2008 at www.clinicaltrials.gov with the identifier of NCT00668655.

Correspondence: Lori A. Johnson, PhD ([email protected]).

Article PDF

087050251.pdf

Article PDF

087050251.pdf

Issue

Cutis - 87(5)

Issue

Cutis - 87(5)

Page Number

251-259